Auspex Pharmaceuticals Receives $84,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Auspex Pharmaceuticals
  • Mailing Address
    3366 North Torrey Pines Court La Jolla, CA 92037
  • Company Description
    Auspex Pharmaceuticals (NASDAQ: ASPX) is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy